| Laurel Jordan, DO | |
|
2020 Arlington, Suite 2, Ada, OK 74820-2822 | |
| (580) 436-9037 | |
| (580) 436-9028 |
| Full Name | Laurel Jordan |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 22 Years |
| Location | 2020 Arlington, Ada, Oklahoma |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720188493 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 34008645 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Norman Regional | Norman, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Norman Regional Providers Specialty Care | 5496900706 | 138 |
News Archive
The aim of personalizing cancer treatments by targeting genomic mutations in the cancer has seen rapid advances in recent years. However, many of these targeted cancer therapies have been more frequently identified for adult patients. Recognizing a need to further explore genomic profiling in pediatric malignancies, the Hugs for Brady Foundation has committed $300,000 to the precision medicine initiative at Rutgers Cancer Institute of New Jersey.
Electron-beam computed tomography (EBCT) is more accurate than conventional catheter angiography for identifying which adult patients face the greatest risk of sudden death from congenital abnormalities in the arteries supplying blood to the heart, according to a study in the September 2005 issue of Catheterization and Cardiovascular Interventions: Journal of the Society for Cardiovascular Angiography and Interventions.
Sen. Hillary Rodham Clinton (D-N.Y.), who is running for the Democratic presidential nomination, recently signed a pledge to commit to investing $50 billion by 2013 to fight HIV/AIDS domestically and worldwide, the New York Times reports. Clinton also plans to issue a formal policy on the disease, according to the Times (Seelye, "The Caucus," New York Times, 10/26).
Cancer diagnostics company Biomoda, Inc. has received a notice of allowance for a Canadian patent application for a method of using its proprietary porphyrin-based compound that binds to cancer cells and causes them to fluoresce under specific frequencies of light when viewed under a fluorescent microscope.
VBL Therapeutics, a late-stage clinical biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for cancer, today announced positive interim results from an investigator-initiated, Phase 1/2a trial of multiple dose VB-111 in recurrent platinum-resistant Müllerian (ovarian) cancer.
› Verified 4 days ago
| Entity Name | Norman Regional Providers Specialty Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548513773 PECOS PAC ID: 5496900706 Enrollment ID: O20130312000200 |
News Archive
The aim of personalizing cancer treatments by targeting genomic mutations in the cancer has seen rapid advances in recent years. However, many of these targeted cancer therapies have been more frequently identified for adult patients. Recognizing a need to further explore genomic profiling in pediatric malignancies, the Hugs for Brady Foundation has committed $300,000 to the precision medicine initiative at Rutgers Cancer Institute of New Jersey.
Electron-beam computed tomography (EBCT) is more accurate than conventional catheter angiography for identifying which adult patients face the greatest risk of sudden death from congenital abnormalities in the arteries supplying blood to the heart, according to a study in the September 2005 issue of Catheterization and Cardiovascular Interventions: Journal of the Society for Cardiovascular Angiography and Interventions.
Sen. Hillary Rodham Clinton (D-N.Y.), who is running for the Democratic presidential nomination, recently signed a pledge to commit to investing $50 billion by 2013 to fight HIV/AIDS domestically and worldwide, the New York Times reports. Clinton also plans to issue a formal policy on the disease, according to the Times (Seelye, "The Caucus," New York Times, 10/26).
Cancer diagnostics company Biomoda, Inc. has received a notice of allowance for a Canadian patent application for a method of using its proprietary porphyrin-based compound that binds to cancer cells and causes them to fluoresce under specific frequencies of light when viewed under a fluorescent microscope.
VBL Therapeutics, a late-stage clinical biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for cancer, today announced positive interim results from an investigator-initiated, Phase 1/2a trial of multiple dose VB-111 in recurrent platinum-resistant Müllerian (ovarian) cancer.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Laurel Jordan, DO 530 N Monte Vista St, Suite A, Ada, OK 74820-4675 Ph: (580) 436-7101 | Laurel Jordan, DO 2020 Arlington, Suite 2, Ada, OK 74820-2822 Ph: (580) 436-9037 |
News Archive
The aim of personalizing cancer treatments by targeting genomic mutations in the cancer has seen rapid advances in recent years. However, many of these targeted cancer therapies have been more frequently identified for adult patients. Recognizing a need to further explore genomic profiling in pediatric malignancies, the Hugs for Brady Foundation has committed $300,000 to the precision medicine initiative at Rutgers Cancer Institute of New Jersey.
Electron-beam computed tomography (EBCT) is more accurate than conventional catheter angiography for identifying which adult patients face the greatest risk of sudden death from congenital abnormalities in the arteries supplying blood to the heart, according to a study in the September 2005 issue of Catheterization and Cardiovascular Interventions: Journal of the Society for Cardiovascular Angiography and Interventions.
Sen. Hillary Rodham Clinton (D-N.Y.), who is running for the Democratic presidential nomination, recently signed a pledge to commit to investing $50 billion by 2013 to fight HIV/AIDS domestically and worldwide, the New York Times reports. Clinton also plans to issue a formal policy on the disease, according to the Times (Seelye, "The Caucus," New York Times, 10/26).
Cancer diagnostics company Biomoda, Inc. has received a notice of allowance for a Canadian patent application for a method of using its proprietary porphyrin-based compound that binds to cancer cells and causes them to fluoresce under specific frequencies of light when viewed under a fluorescent microscope.
VBL Therapeutics, a late-stage clinical biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for cancer, today announced positive interim results from an investigator-initiated, Phase 1/2a trial of multiple dose VB-111 in recurrent platinum-resistant Müllerian (ovarian) cancer.
› Verified 4 days ago
Miss Lucretia Renee Barker, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1921 Stonecipher Dr, Ada, OK 74820 Phone: 580-436-3980 Fax: 580-421-6283 | |
Miranda Dawn Knight-brown, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 807 N Monte Vista St, Ada, OK 74820 Phone: 580-332-8855 Fax: 580-332-7374 | |
Richard Mcclain, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1921 Stonecipher Boulevard, Ada, OK 74820 Phone: 580-421-6200 Fax: 580-421-6209 | |
Charles Whiting, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1921 Stonecipher Blvd, Ada, OK 74820 Phone: 580-421-6200 Fax: 580-421-6209 | |
Michael Marvin, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1921 Stonecipher Blvd, Ada, OK 74820 Phone: 580-436-3980 Fax: 580-421-6209 | |
Dr. Mahate Ann Parker, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1921 Stonecipher Dr, Ada, OK 74820 Phone: 580-436-3980 Fax: 580-421-6283 | |
John C Siegle, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 807 N Monte Vista St, Ada, OK 74820 Phone: 580-332-8855 Fax: 580-332-7374 |